← Back
$TNGX All transactions

Tango Therapeutics, Inc.

A

$ Value

$0

Shares

222,132

Price

$0

Filed

Feb 4

Insider

Name

Weber Barbara

Title

Director, Executive Chair

CIK

0001800670

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

222,132

Footnotes

These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in full on February 1, 2027, subject to the Reporting Person's continuous service with the Issuer as of such vesting date. | The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. | Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. | Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. | This option shall vest and become exercisable in 12 equal monthly installments following January 1, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Filing Info

Accession No.

0001193125-26-038070

Form Type

4

Issuer CIK

0001819133

Weber Barbara's History

Date Ticker Type Value
2026-02-03 TNGX $370K
2026-02-03 TNGX $4K
2026-02-02 TNGX A $0
2026-02-02 TNGX A $0

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$2.7M 2026-04-15